Our Pricing

Golden Dose Wegovy: Complete UK Guide to the 2.4mg Maintenance Dose

The golden dose Wegovy refers to the 2.4mg maintenance dose of semaglutide, representing the maximum therapeutic strength shown in clinical trials to deliver optimal weight loss results. At Cured Pharmacy, we provide this maintenance dose at the cheapest UK price from £69.00, with next-day delivery available across the United Kingdom. All Wegovy prescriptions require a clinical assessment by our UK-registered prescribers to ensure safe, personalised treatment.

What Is the Golden Dose Wegovy and Why Does It Matter?

The golden dose Wegovy is the pharmaceutical term for the 2.4mg weekly maintenance dose of semaglutide, the final and most effective strength in the Wegovy dose escalation schedule. This dose earned its 'golden' designation because clinical data from the STEP trials demonstrated that participants reaching and maintaining 2.4mg achieved an average weight loss of 15-17% of their initial body weight over 68 weeks[1]. The term reflects both the clinical efficacy and the therapeutic endpoint of the treatment protocol.

Reaching the golden dose Wegovy typically occurs after 16-20 weeks of gradual dose escalation, starting from 0.25mg and progressing through 0.5mg, 1mg, and 1.7mg doses. This stepwise approach allows your body to adapt to semaglutide's effects on appetite regulation and gastric emptying, minimising gastrointestinal side effects whilst building towards maximum therapeutic benefit[2]. Our clinical team at Cured Pharmacy guides patients through this entire escalation pathway, ensuring safe progression to the maintenance dose.

The 2.4mg golden dose works by activating GLP-1 receptors in the brain's appetite centres, reducing hunger signals and increasing feelings of fullness after smaller meals. At this maintenance strength, semaglutide also slows gastric emptying and improves glycaemic control, even in patients without diabetes[3]. These combined mechanisms make the golden dose Wegovy particularly effective for long-term weight management when combined with lifestyle modifications.

Clinical Evidence Supporting the Golden Dose Wegovy

The STEP 1 trial, published in the New England Journal of Medicine, enrolled 1,961 adults with obesity and demonstrated that 2.4mg semaglutide produced a mean weight loss of 14.9% compared to 2.4% with placebo over 68 weeks[1]. Importantly, 86.4% of participants on the golden dose Wegovy achieved at least 5% weight loss, whilst 69.1% achieved 10% or greater reduction in body weight. These results established the 2.4mg dose as the therapeutic gold standard for semaglutide weight management.

Subsequent STEP trials confirmed the golden dose Wegovy's efficacy across diverse populations, including patients with type 2 diabetes (STEP 2) and those maintaining weight loss after initial non-pharmacological intervention (STEP 4)[2]. The consistency of results across these studies, combined with favourable cardiovascular safety data, led to MHRA approval and NICE guidance supporting semaglutide 2.4mg for weight management in the UK.

Golden Dose Wegovy Pricing and UK Availability at Cured Pharmacy

At Cured Pharmacy, the golden dose Wegovy is available from £69.00 per month, representing the cheapest UK price for this maintenance dose strength. This transparent pricing includes your 2.4mg pre-filled injection pens, clinical assessment by our UK-registered prescribers, and next-day delivery across England, Scotland, Wales, and Northern Ireland. New patients receive £20 off their first order using code Weightlossnew, reducing the initial cost to £69.00.

Our pricing structure reflects our commitment to making the golden dose Wegovy accessible whilst maintaining the highest pharmaceutical standards. All Wegovy supplied by Cured Pharmacy is sourced directly from UK-licensed wholesalers, ensuring you receive genuine Novo Nordisk medication with full cold-chain integrity. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), personally oversees dispensing protocols to guarantee product authenticity and storage compliance.

The golden dose Wegovy requires ongoing prescription from a UK-registered prescriber, with regular clinical reviews to monitor treatment response and safety parameters. At Cured Pharmacy, these follow-up consultations are included in your treatment pathway at no additional cost, ensuring continuous clinical oversight as you maintain the 2.4mg dose for long-term weight management.

How to Reach the Golden Dose Wegovy Safely

Achieving the golden dose Wegovy requires following a specific dose escalation schedule designed to optimise tolerability whilst building therapeutic effect. The standard pathway begins with 0.25mg weekly for four weeks, followed by 0.5mg for four weeks, then 1mg for four weeks, 1.7mg for four weeks, and finally the 2.4mg maintenance dose[3]. This 16-week escalation minimises gastrointestinal side effects such as nausea and vomiting, which are most common when doses are increased too rapidly.

Some patients may require modified escalation timelines based on individual tolerability and clinical response. Our prescribers at Cured Pharmacy assess your progress at each dose level, potentially extending time at lower doses if you experience persistent side effects, or in rare cases, determining that a sub-maximal dose provides optimal benefit with better tolerability. The goal is always to reach the golden dose Wegovy if clinically appropriate, as this delivers maximum weight loss efficacy.

Once established on the 2.4mg golden dose, most patients continue this strength indefinitely as part of long-term weight management. Clinical trials show that discontinuing semaglutide typically results in weight regain, highlighting the importance of viewing the golden dose Wegovy as an ongoing treatment rather than a short-term intervention[4]. Regular monitoring of weight, blood pressure, and metabolic markers helps ensure sustained benefit and safety.

Managing Side Effects at the Golden Dose Wegovy

The most common side effects at the golden dose Wegovy are gastrointestinal, including nausea (44% of trial participants), diarrhoea (30%), vomiting (24%), and constipation (24%)[1]. These effects are typically mild to moderate and diminish over time as your body adapts to the 2.4mg dose. Eating smaller meals, avoiding high-fat foods, and staying well-hydrated can significantly reduce symptom severity.

More serious but rare adverse effects requiring immediate medical attention include severe abdominal pain (potential pancreatitis), persistent vomiting leading to dehydration, visual changes, or signs of thyroid nodules. Our clinical team provides comprehensive safety guidance when prescribing the golden dose Wegovy, including written information on recognising warning signs and when to seek urgent medical review.

Golden Dose Wegovy vs Other Semaglutide Strengths

The golden dose Wegovy at 2.4mg delivers significantly greater weight loss than lower semaglutide doses used for diabetes management. Ozempic, licensed for type 2 diabetes, uses maximum doses of 1mg or 2mg weekly, which produce average weight loss of 6-7% compared to 15-17% with the 2.4mg golden dose[2]. This dose difference explains why Wegovy received separate MHRA licensing specifically for weight management, whilst Ozempic remains indicated primarily for glycaemic control.

Some prescribers initially used Ozempic off-label for weight loss due to Wegovy supply constraints, but this practice has limitations. The golden dose Wegovy provides a higher therapeutic ceiling for weight reduction, and the Wegovy pen device is specifically designed for the dose escalation schedule required to reach 2.4mg safely. At Cured Pharmacy, we ensure patients receive the appropriate licensed medication for their clinical indication, with Wegovy prescribed specifically for weight management at the full golden dose strength.

Patients sometimes ask whether staying at 1.7mg instead of progressing to the golden dose Wegovy is sufficient. Whilst 1.7mg does produce meaningful weight loss, clinical trial data consistently shows superior outcomes at 2.4mg, with an additional 2-3% body weight reduction on average[3]. Unless tolerability issues prevent escalation, reaching the golden dose maximises your likelihood of achieving clinically significant weight loss and associated metabolic improvements.

Who Can Use the Golden Dose Wegovy in the UK?

The golden dose Wegovy is licensed in the UK for adults with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea[4]. NICE guidance additionally recommends considering semaglutide 2.4mg for patients who have not achieved adequate weight loss with lifestyle interventions alone, and who are committed to ongoing dietary and physical activity modifications alongside medication.

Certain medical conditions preclude use of the golden dose Wegovy, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or diabetic retinopathy requiring active treatment. Pregnancy and breastfeeding are absolute contraindications, as semaglutide's effects on foetal development have not been established. Our prescribers conduct thorough medical history reviews to identify any contraindications before approving treatment.

At Cured Pharmacy, accessing the golden dose Wegovy begins with a comprehensive online clinical assessment completed by UK-registered prescribers. This evaluation covers your weight history, previous weight loss attempts, current medications, and relevant medical conditions to determine suitability for semaglutide 2.4mg. The assessment typically takes under three minutes to complete, with prescribing decisions made within 24 hours and next-day delivery available once approved.

Golden Dose Wegovy for Long-Term Weight Management

Clinical evidence supports using the golden dose Wegovy as a long-term treatment rather than a short course. The STEP 4 trial demonstrated that patients who achieved weight loss on 2.4mg semaglutide and then switched to placebo regained two-thirds of their lost weight over 48 weeks, whilst those continuing the golden dose maintained their weight reduction and lost additional weight[4]. This underscores that semaglutide addresses the biological mechanisms driving weight regain, requiring ongoing treatment for sustained benefit.

Long-term safety data extending to two years shows the golden dose Wegovy maintains a favourable benefit-risk profile with continued use, with no new safety signals emerging beyond the initial trial period[2]. Regular clinical monitoring, typically every three to six months, ensures ongoing appropriateness of treatment and allows dose adjustment if needed based on weight loss response and tolerability.

Getting Started with Golden Dose Wegovy at Cured Pharmacy

Beginning your golden dose Wegovy treatment through Cured Pharmacy starts with our online clinical assessment, accessible 24/7 through our secure platform. You'll provide detailed information about your weight history, current health status, medications, and weight loss goals, which our UK-registered prescribers review to determine suitability for semaglutide treatment. This digital consultation meets the same clinical standards as face-to-face GP appointments, ensuring safe, appropriate prescribing.

Once approved, your initial Wegovy prescription will be for the 0.25mg starting dose, with clear instructions on the escalation schedule leading to the golden dose over 16-20 weeks. We provide comprehensive injection technique guidance, storage instructions (Wegovy must be refrigerated at 2-8°C), and detailed information on managing potential side effects. Your medication ships via next-day courier in temperature-controlled packaging, with discreet labelling to protect your privacy.

Ongoing support throughout your journey to the golden dose Wegovy includes unlimited messaging access to our pharmacy team, regular prescriber check-ins at each dose escalation, and automatic prescription renewals to ensure uninterrupted treatment. At Cured Pharmacy, we view weight management as a partnership between patient, prescriber, and pharmacist, with the golden dose Wegovy as one component of a comprehensive approach including nutrition and activity guidance. New patients Save £20 on their first order using code Weightlossnew, making the initial month just £69.00.

Scientific References

1. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
2. Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., ... & Lingvay, I. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971-984. [accessed 15 August 2026]
3. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Sørrig, R. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
4. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., ... & Wharton, S. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 15 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.